Literature DB >> 26378778

Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns.

Laura Goodliffe1, Brenda L Coleman1,2, Allison J McGeer2,3.   

Abstract

After a Canadian hospital's official influenza vaccination campaign concluded in the 2011-2012 and 2012-2013 influenza seasons, study nurses provided additional vaccination mobile cart hours and the added choice of an intradermal injection. An additional 2.1% of staff in the first and 1.4% in the second season were vaccinated during the study with 90-99% preferring the intradermal injection or having no preference. All 13 staff who attempted self-injection with the intradermal vaccine in 2012-2013 were successful on their first attempt. Offering alternatives to intramuscular vaccines may increase rates of vaccination.

Keywords:  healthcare; hospital; immunization program; influenza vaccines; intradermal; pain perception

Mesh:

Substances:

Year:  2015        PMID: 26378778      PMCID: PMC5054788          DOI: 10.1080/21645515.2015.1072665

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  14 in total

1.  Control of influenza A on a bone marrow transplant unit.

Authors:  D M Weinstock; J Eagan; S A Malak; M Rogers; H Wallace; T E Kiehn; K A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2000-11       Impact factor: 3.254

2.  Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.

Authors:  Roman Prymula; Gaye Usluer; Serdar Altinel; Radka Sichova; Françoise Weber
Journal:  Adv Ther       Date:  2012-01-03       Impact factor: 3.845

3.  Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina.

Authors:  Peter Eizenberg; Robert Booy; Nadim Naser; Glen Mason; Daniel Stamboulian; Françoise Weber
Journal:  Adv Ther       Date:  2011-07-11       Impact factor: 3.845

4.  Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial.

Authors:  Sang Hoon Han; Jun Hee Woo; Francoise Weber; Woo Joo Kim; Kyong Ran Peck; Sang Il Kim; Young Hwa Choi; June Myung Kim
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

5.  Novel use of the intranet to document health care personnel participation in a mandatory influenza vaccination reporting program.

Authors:  Mary Bertin; Michele Scarpelli; Andrew W Proctor; John Sharp; Ethel Robitson; Todd Donnelly; Claire Young; Steven M Gordon
Journal:  Am J Infect Control       Date:  2007-02       Impact factor: 2.918

6.  Improving influenza vaccination rates in the workplace: a randomized trial.

Authors:  Mary Patricia Nowalk; Chyongchiou J Lin; Seth L Toback; Matthew D Rousculp; Charles Eby; Mahlon Raymund; Richard K Zimmerman
Journal:  Am J Prev Med       Date:  2009-12-24       Impact factor: 5.043

Review 7.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

8.  National seasonal influenza vaccination survey in Europe, 2008.

Authors:  J Mereckiene; S Cotter; A Nicoll; D Levy-Bruhl; A Ferro; G Tridente; G Zanoni; P Berra; S Salmaso; D O'Flanagan; D O Flanagan
Journal:  Euro Surveill       Date:  2008-10-23

9.  Use of a mandatory declination form in a program for influenza vaccination of healthcare workers.

Authors:  Bruce S Ribner; Cynthia Hall; James P Steinberg; William A Bornstein; Rosette Chakkalakal; Amir Emamifar; Irving Eichel; Peter C Lee; Penny Z Castellano; Gilbert D Grossman
Journal:  Infect Control Hosp Epidemiol       Date:  2008-04       Impact factor: 3.254

10.  Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.

Authors:  Jiri Beran; Arvydas Ambrozaitis; Alvydas Laiskonis; Narseta Mickuviene; Patrick Bacart; Yvan Calozet; Etienne Demanet; Stephane Heijmans; Paul Van Belle; Françoise Weber; Camille Salamand
Journal:  BMC Med       Date:  2009-04-02       Impact factor: 8.775

View more
  1 in total

1.  Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.

Authors:  Jay V DePasse; Mary Patricia Nowalk; Kenneth J Smith; Jonathan M Raviotta; Eunha Shim; Richard K Zimmerman; Shawn T Brown
Journal:  Vaccine       Date:  2017-06-09       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.